Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC
Nonalcoholic fatty liver disease (NAFLD) is the leading contributor to the global burden of chronic liver diseases. The phenotypic umbrella of NAFLD spans from simple and reversible steatosis to nonalcoholic steatohepatitis (NASH), which may worsen into cirrhosis and hepatocellular carcinoma (HCC)....
Guardado en:
Autores principales: | Paola Dongiovanni, Marica Meroni, Miriam Longo, Silvia Fargion, Anna Ludovica Fracanzani |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/41ee9aeec43048779c58796f6c87422b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
por: Chunye Zhang, et al.
Publicado: (2021) -
Circulatory <i>Endothelin 1-</i>Regulating RNAs Panel: Promising Biomarkers for Non-Invasive NAFLD/NASH Diagnosis and Stratification: Clinical and Molecular Pilot Study
por: Reda Albadawy, et al.
Publicado: (2021) -
Estimating Drug Efficacy with a Diet-Induced NASH Model in Chimeric Mice with Humanized Livers
por: Keishi Kisoh, et al.
Publicado: (2021) -
Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
por: Rocío Gallego-Durán, et al.
Publicado: (2021) -
Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation
por: Na Wu, et al.
Publicado: (2021)